About Ronald Reagan UCLA Medical Center, Drug Information Center, Department of Pharmaceutical Services
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at Ronald Reagan UCLA Medical Center, Drug Information Center, Department of Pharmaceutical Services
During the past decade, Ronald Reagan UCLA Medical Center, Drug Information Center, Department of Pharmaceutical Services conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 3 clinical trials were completed, i.e. on
average, 300% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Ronald Reagan UCLA Medical Center, Drug Information Center, Department of Pharmaceutical Services"
#1 collaborator was "Astellas Pharma Inc" with 1 trials as a collaborator, "Medivation LLC, a wholly owned subsidiary of Pfizer Inc." with 1 trials as a collaborator and "UCB Pharma" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at Ronald Reagan UCLA Medical Center, Drug Information Center, Department of Pharmaceutical Services
According to Clinical.Site data, the most researched conditions in "Ronald Reagan UCLA Medical Center, Drug Information Center, Department of Pharmaceutical Services" are
"Lymphoma, Non-Hodgkin" (1 trials), "Melanoma" (1 trials), "Prostate Cancer" (1 trials) and "Stage IV Pancreatic Cancer" (1 trials). Many other conditions were trialed in "Ronald Reagan UCLA Medical Center, Drug Information Center, Department of Pharmaceutical Services" in a lesser frequency.
Clinical Trials Intervention Types at Ronald Reagan UCLA Medical Center, Drug Information Center, Department of Pharmaceutical Services
Most popular intervention types in "Ronald Reagan UCLA Medical Center, Drug Information Center, Department of Pharmaceutical Services" are "Drug" (4 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (2 trials), "BGJ398" (1 trials), "BKM120" (1 trials), "Enzalutamide" (1 trials) and "Gemcitabine" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Ronald Reagan UCLA Medical Center, Drug Information Center, Department of Pharmaceutical Services
The vast majority of trials in "Ronald Reagan UCLA Medical Center, Drug Information Center, Department of Pharmaceutical Services" are
3 trials for "All" genders and 1 trials for "Male" genders.
Clinical Trials Status at Ronald Reagan UCLA Medical Center, Drug Information Center, Department of Pharmaceutical Services
Currently, there are NaN active trials in "Ronald Reagan UCLA Medical Center, Drug Information Center, Department of Pharmaceutical Services".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Ronald Reagan UCLA Medical Center, Drug Information Center, Department of Pharmaceutical Services,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Ronald Reagan UCLA Medical Center, Drug Information Center, Department of Pharmaceutical Services, 1 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".